BIOMAT Database Logo BIOMAT Database Logo

Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine for the prevention of genital warts in males: profile report. demail@springer.com. 2012

Karly P Garnock-Jones, and Anna R Giuliano
Adis, Auckland, New Zealand.

†Adapted and reproduced from the original article published in Drugs 2011; 71 (5): 591-602.[1].

UI MeSH Term Description Entries
D008297 Male Males
D003218 Condylomata Acuminata Sexually transmitted form of anogenital warty growth caused by the human papillomaviruses. Genital Warts,Venereal Warts,Warts, Genital,Warts, Venereal,Genital Wart,Venereal Wart,Wart, Genital,Wart, Venereal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D052685 Alphapapillomavirus A genus of DNA viruses in the family PAPILLOMAVIRIDAE. They preferentially infect the anogenital and ORAL MUCOSA in humans and primates, causing both malignant and benign neoplasms. Cutaneous lesions are also seen. Alphapapillomaviruses
D053918 Papillomavirus Vaccines Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS. HPV Vaccine,Human Papilloma Virus Vaccine,Human Papillomavirus Vaccine,Human Papillomavirus Vaccines,Papillomavirus Vaccine,HPV Vaccines,Human Papilloma Virus Vaccines,Papillomavirus Vaccine, Human,Papillomavirus Vaccines, Human,Vaccine, HPV,Vaccine, Human Papillomavirus,Vaccine, Papillomavirus,Vaccines, Human Papillomavirus,Vaccines, Papillomavirus
D030361 Papillomavirus Infections Neoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression. HPV Infection,Human Papillomavirus Infection,HPV Infections,Human Papillomavirus Infections,Papillomavirus Infection,Papillomavirus Infection, Human,Papillomavirus Infections, Human

Related Publications

Karly P Garnock-Jones, and Anna R Giuliano
Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil): profile report.
January 2006, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,
Karly P Garnock-Jones, and Anna R Giuliano
Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil).
January 2006, Drugs,
Karly P Garnock-Jones, and Anna R Giuliano
[Quadrivalent HPV 6/11/16/18 vaccine].
November 2007, Ugeskrift for laeger,
Karly P Garnock-Jones, and Anna R Giuliano
Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
October 2011, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,
Karly P Garnock-Jones, and Anna R Giuliano
Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the prevention of premalignant genital lesions, genital cancer and genital warts in women.
December 2010, Drugs,
Karly P Garnock-Jones, and Anna R Giuliano
Condyloma accuminatum treated with recombinant quadrivalent human papillomavirus vaccine (types 6, 11, 16, 18).
June 2011, Journal of the American Academy of Dermatology,
Karly P Garnock-Jones, and Anna R Giuliano
Detection of human papillomavirus types 6, 11, 16 and 18 in genital warts and cervical neoplasia.
January 1986, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Karly P Garnock-Jones, and Anna R Giuliano
Immunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years old.
February 2012, Clinical and vaccine immunology : CVI,
Karly P Garnock-Jones, and Anna R Giuliano
A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil).
February 2008, Therapeutics and clinical risk management,
Karly P Garnock-Jones, and Anna R Giuliano
The impact of human papillomavirus (HPV) types 6, 11 in women with genital warts.
November 2012, Archives of gynecology and obstetrics,
Copied contents to your clipboard!